Market revenue in 2022 | USD 104.1 million |
Market revenue in 2030 | USD 321.6 million |
Growth rate | 15.1% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single cell analysis market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 54.76% in 2022. Horizon Databook has segmented the Canada single cell analysis market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is recognized for its advanced healthcare and life sciences solutions. The country is home to highly skilled and experienced life sciences professionals. It hosts an innovative environment for the life sciences industry, with broad research networks, abundant partnership opportunities, first-rate academic institutions, and lower costs.
The Canadian economy is expected to be driven by the integration of life science innovation, funding support, and operational expansion utilizing big data, AI, advanced cell & gene therapies, and platform technologies such as 3D printing.
Canada has more than 900 biotech companies spread across all regions and stages of development. This diversity is reflected in the therapies and products that the country offers. The Canadian government granted USD 6.5 million to Toronto Innovation Acceleration Partners (TIAP) in October 2020.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada single cell analysis market , including forecasts for subscribers. This country databook contains high-level insights into Canada single cell analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account